Caulis Sargentodoxae Prescription Plays a Therapeutic Role with Decreased Inflammatory Cytokines in Peritoneal Fluid in the Rat Endometriosis Model

Caulis Sargentodoxae prescription has been confirmed by the gynecological clinical observation to be effective in the treatment of endometriosis (EMs), and inflammatory cytokines were involved in EMs. In this paper, animal experiments were designed to explain anti-inflammatory mechanisms of Caulis S...

Full description

Saved in:
Bibliographic Details
Published in:Evidence-based complementary and alternative medicine 2020, Vol.2020 (2020), p.1-9
Main Authors: Sun, Zhaogui, Niu, Yanan, Yu, Lin, Shi, Yan, Cao, Yang, Zhuang, Meng-fei, Zhang, Ting-ting
Format: Article
Language:English
Subjects:
Abdomen
Animal experimentation
Animal research
Anti-inflammatory drugs
Antibodies
Binding sites
Celecoxib
Chinese medicine
Cyclooxygenase-2
Cytokines
Drug dosages
Endometriosis
Endometrium
Enzyme-linked immunosorbent assay
Experiments
Health aspects
Immunohistochemistry
Infertility
Inflammation
Interleukin 1
Interleukin 2
Interleukin 6
Laboratory animals
Menstruation
mRNA
Oral administration
Ovariectomy
Ovaries
Peritoneal fluid
Peritoneum
Physiology
Polymerase chain reaction
Prostaglandin E2
Prostaglandin endoperoxide synthase
RNA
Transplantation
Tumor necrosis factor-α
Uterus
Western blotting
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c499t-4dc2ee55315d980f4e8febd459b14632d5ce29498ed5d76a7e42de9fed1349bb3
cites cdi_FETCH-LOGICAL-c499t-4dc2ee55315d980f4e8febd459b14632d5ce29498ed5d76a7e42de9fed1349bb3
container_end_page 9
container_issue 2020
container_start_page 1
container_title Evidence-based complementary and alternative medicine
container_volume 2020
creator Sun, Zhaogui
Niu, Yanan
Yu, Lin
Shi, Yan
Cao, Yang
Zhuang, Meng-fei
Zhang, Ting-ting
description Caulis Sargentodoxae prescription has been confirmed by the gynecological clinical observation to be effective in the treatment of endometriosis (EMs), and inflammatory cytokines were involved in EMs. In this paper, animal experiments were designed to explain anti-inflammatory mechanisms of Caulis Sargentodoxae prescription on endometriosis. The EMs model was established by autoplastic transplantation, and rats were randomly divided into seven groups: normal control group, model group, ovariectomized group, gestrinone (Western medicine) group, Caulis Sargentodoxae prescription (Chinese medicine) group, celecoxib (inhibitor) group, and combination (Chinese medicine + inhibitor) group. After oral administration for 21 days, the growth inhibitory rates of the ectopic endometria in treatment groups were evaluated, and the levels of inflammatory cytokines in the serum and peritoneal fluid were determined by ELISA, as well as the expression of prostaglandin endoperoxide synthase 2 (PTGS2) in the ectopic endometrial tissues was detected by real-time polymerase chain reaction, immunohistochemistry, and western blotting. The growth inhibitory rates of the ectopic endometria were significantly higher in the Caulis Sargentodoxae prescription group and gestrinone group, in comparison with the model group p
doi_str_mv 10.1155/2020/9627907
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7275949</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A635580280</galeid><sourcerecordid>A635580280</sourcerecordid><originalsourceid>FETCH-LOGICAL-c499t-4dc2ee55315d980f4e8febd459b14632d5ce29498ed5d76a7e42de9fed1349bb3</originalsourceid><addsrcrecordid>eNqNkkFvFCEYhidGY2v15tmQeDHRtcDAABeTZm21SY1NrYk3wg7f7FKZYQXGur_DPyyTXdfqyRMEnjx8L3mr6inBrwnh_Jhiio9VQ4XC4l51SAQjM0alvL_fiy8H1aOUbjCmSgjxsDqoKVdc8Pqw-jk3o3cJfTJxCUMONvwwgC4jpDa6dXZhQJfebBIy6HoF0axhzK5FV8EDunV5hd5CG8EksOh86Lzpe5ND3KD5JoevboCEXDFAdDkMYDw686Oz01leAboyGZ0ONvSQowupjPEhWPCPqwed8Qme7Naj6vPZ6fX8_ezi47vz-cnFrGVK5RmzLQXgvCbcKok7BrKDhWVcLQhramp5C1QxJcFyKxojgFELqgNLaqYWi_qoerP1rsdFD7Yt-aPxeh1db-JGB-P03zeDW-ll-K4FFbyIi-DFThDDtxFS1r1LLXhvBghj0pQRKcpfE1zQ5_-gN2GMQ4k3URhL1Yg71NJ40G7oQnm3naT6pKk5l5jKiXq1pdoYUorQ7UcmWE-d0FMn9K4TBX92N-Ye_l2CArzcAis3WHPr_lMHhYHO_KEJlw2T9S_758sI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2410089670</pqid></control><display><type>article</type><title>Caulis Sargentodoxae Prescription Plays a Therapeutic Role with Decreased Inflammatory Cytokines in Peritoneal Fluid in the Rat Endometriosis Model</title><source>Publicly Available Content Database</source><source>Wiley Open Access</source><creator>Sun, Zhaogui ; Niu, Yanan ; Yu, Lin ; Shi, Yan ; Cao, Yang ; Zhuang, Meng-fei ; Zhang, Ting-ting</creator><contributor>Su, Shan-Yu ; Shan-Yu Su</contributor><creatorcontrib>Sun, Zhaogui ; Niu, Yanan ; Yu, Lin ; Shi, Yan ; Cao, Yang ; Zhuang, Meng-fei ; Zhang, Ting-ting ; Su, Shan-Yu ; Shan-Yu Su</creatorcontrib><description>Caulis Sargentodoxae prescription has been confirmed by the gynecological clinical observation to be effective in the treatment of endometriosis (EMs), and inflammatory cytokines were involved in EMs. In this paper, animal experiments were designed to explain anti-inflammatory mechanisms of Caulis Sargentodoxae prescription on endometriosis. The EMs model was established by autoplastic transplantation, and rats were randomly divided into seven groups: normal control group, model group, ovariectomized group, gestrinone (Western medicine) group, Caulis Sargentodoxae prescription (Chinese medicine) group, celecoxib (inhibitor) group, and combination (Chinese medicine + inhibitor) group. After oral administration for 21 days, the growth inhibitory rates of the ectopic endometria in treatment groups were evaluated, and the levels of inflammatory cytokines in the serum and peritoneal fluid were determined by ELISA, as well as the expression of prostaglandin endoperoxide synthase 2 (PTGS2) in the ectopic endometrial tissues was detected by real-time polymerase chain reaction, immunohistochemistry, and western blotting. The growth inhibitory rates of the ectopic endometria were significantly higher in the Caulis Sargentodoxae prescription group and gestrinone group, in comparison with the model group p&lt;0.05. In the Caulis Sargentodoxae prescription group, the levels of inflammatory cytokines including IL-1, IL-2, IL-6, TNF-α, and PGE2 were all reduced in the serum and peritoneal fluid p&lt;0.05. In addition, the specific expression of PTGS2 in the ectopic endometrial tissues significantly decreased in the Caulis Sargentodoxae prescription group and PTGS2 inhibitor celecoxib group both at mRNA and protein levels, but in the steroid hormone drug gestrinone group not at the mRNA level. So, Caulis Sargentodoxae prescription has a reliable therapeutic effect on the EMs by its comprehensive anti-inflammatory roles, possibly in a way different from gestrinone.</description><identifier>ISSN: 1741-427X</identifier><identifier>EISSN: 1741-4288</identifier><identifier>DOI: 10.1155/2020/9627907</identifier><identifier>PMID: 32595753</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Abdomen ; Animal experimentation ; Animal research ; Anti-inflammatory drugs ; Antibodies ; Binding sites ; Celecoxib ; Chinese medicine ; Cyclooxygenase-2 ; Cytokines ; Drug dosages ; Endometriosis ; Endometrium ; Enzyme-linked immunosorbent assay ; Experiments ; Health aspects ; Immunohistochemistry ; Infertility ; Inflammation ; Interleukin 1 ; Interleukin 2 ; Interleukin 6 ; Laboratory animals ; Menstruation ; mRNA ; Oral administration ; Ovariectomy ; Ovaries ; Peritoneal fluid ; Peritoneum ; Physiology ; Polymerase chain reaction ; Prostaglandin E2 ; Prostaglandin endoperoxide synthase ; RNA ; Transplantation ; Tumor necrosis factor-α ; Uterus ; Western blotting</subject><ispartof>Evidence-based complementary and alternative medicine, 2020, Vol.2020 (2020), p.1-9</ispartof><rights>Copyright © 2020 Mengfei Zhuang et al.</rights><rights>COPYRIGHT 2020 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2020 Mengfei Zhuang et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2020 Mengfei Zhuang et al. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c499t-4dc2ee55315d980f4e8febd459b14632d5ce29498ed5d76a7e42de9fed1349bb3</citedby><cites>FETCH-LOGICAL-c499t-4dc2ee55315d980f4e8febd459b14632d5ce29498ed5d76a7e42de9fed1349bb3</cites><orcidid>0000-0002-7531-9994 ; 0000-0002-1919-1471</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2410089670/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2410089670?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,4009,25732,27902,27903,27904,36991,36992,44569,74873</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32595753$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Su, Shan-Yu</contributor><contributor>Shan-Yu Su</contributor><creatorcontrib>Sun, Zhaogui</creatorcontrib><creatorcontrib>Niu, Yanan</creatorcontrib><creatorcontrib>Yu, Lin</creatorcontrib><creatorcontrib>Shi, Yan</creatorcontrib><creatorcontrib>Cao, Yang</creatorcontrib><creatorcontrib>Zhuang, Meng-fei</creatorcontrib><creatorcontrib>Zhang, Ting-ting</creatorcontrib><title>Caulis Sargentodoxae Prescription Plays a Therapeutic Role with Decreased Inflammatory Cytokines in Peritoneal Fluid in the Rat Endometriosis Model</title><title>Evidence-based complementary and alternative medicine</title><addtitle>Evid Based Complement Alternat Med</addtitle><description>Caulis Sargentodoxae prescription has been confirmed by the gynecological clinical observation to be effective in the treatment of endometriosis (EMs), and inflammatory cytokines were involved in EMs. In this paper, animal experiments were designed to explain anti-inflammatory mechanisms of Caulis Sargentodoxae prescription on endometriosis. The EMs model was established by autoplastic transplantation, and rats were randomly divided into seven groups: normal control group, model group, ovariectomized group, gestrinone (Western medicine) group, Caulis Sargentodoxae prescription (Chinese medicine) group, celecoxib (inhibitor) group, and combination (Chinese medicine + inhibitor) group. After oral administration for 21 days, the growth inhibitory rates of the ectopic endometria in treatment groups were evaluated, and the levels of inflammatory cytokines in the serum and peritoneal fluid were determined by ELISA, as well as the expression of prostaglandin endoperoxide synthase 2 (PTGS2) in the ectopic endometrial tissues was detected by real-time polymerase chain reaction, immunohistochemistry, and western blotting. The growth inhibitory rates of the ectopic endometria were significantly higher in the Caulis Sargentodoxae prescription group and gestrinone group, in comparison with the model group p&lt;0.05. In the Caulis Sargentodoxae prescription group, the levels of inflammatory cytokines including IL-1, IL-2, IL-6, TNF-α, and PGE2 were all reduced in the serum and peritoneal fluid p&lt;0.05. In addition, the specific expression of PTGS2 in the ectopic endometrial tissues significantly decreased in the Caulis Sargentodoxae prescription group and PTGS2 inhibitor celecoxib group both at mRNA and protein levels, but in the steroid hormone drug gestrinone group not at the mRNA level. So, Caulis Sargentodoxae prescription has a reliable therapeutic effect on the EMs by its comprehensive anti-inflammatory roles, possibly in a way different from gestrinone.</description><subject>Abdomen</subject><subject>Animal experimentation</subject><subject>Animal research</subject><subject>Anti-inflammatory drugs</subject><subject>Antibodies</subject><subject>Binding sites</subject><subject>Celecoxib</subject><subject>Chinese medicine</subject><subject>Cyclooxygenase-2</subject><subject>Cytokines</subject><subject>Drug dosages</subject><subject>Endometriosis</subject><subject>Endometrium</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Experiments</subject><subject>Health aspects</subject><subject>Immunohistochemistry</subject><subject>Infertility</subject><subject>Inflammation</subject><subject>Interleukin 1</subject><subject>Interleukin 2</subject><subject>Interleukin 6</subject><subject>Laboratory animals</subject><subject>Menstruation</subject><subject>mRNA</subject><subject>Oral administration</subject><subject>Ovariectomy</subject><subject>Ovaries</subject><subject>Peritoneal fluid</subject><subject>Peritoneum</subject><subject>Physiology</subject><subject>Polymerase chain reaction</subject><subject>Prostaglandin E2</subject><subject>Prostaglandin endoperoxide synthase</subject><subject>RNA</subject><subject>Transplantation</subject><subject>Tumor necrosis factor-α</subject><subject>Uterus</subject><subject>Western blotting</subject><issn>1741-427X</issn><issn>1741-4288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNkkFvFCEYhidGY2v15tmQeDHRtcDAABeTZm21SY1NrYk3wg7f7FKZYQXGur_DPyyTXdfqyRMEnjx8L3mr6inBrwnh_Jhiio9VQ4XC4l51SAQjM0alvL_fiy8H1aOUbjCmSgjxsDqoKVdc8Pqw-jk3o3cJfTJxCUMONvwwgC4jpDa6dXZhQJfebBIy6HoF0axhzK5FV8EDunV5hd5CG8EksOh86Lzpe5ND3KD5JoevboCEXDFAdDkMYDw686Oz01leAboyGZ0ONvSQowupjPEhWPCPqwed8Qme7Naj6vPZ6fX8_ezi47vz-cnFrGVK5RmzLQXgvCbcKok7BrKDhWVcLQhramp5C1QxJcFyKxojgFELqgNLaqYWi_qoerP1rsdFD7Yt-aPxeh1db-JGB-P03zeDW-ll-K4FFbyIi-DFThDDtxFS1r1LLXhvBghj0pQRKcpfE1zQ5_-gN2GMQ4k3URhL1Yg71NJ40G7oQnm3naT6pKk5l5jKiXq1pdoYUorQ7UcmWE-d0FMn9K4TBX92N-Ye_l2CArzcAis3WHPr_lMHhYHO_KEJlw2T9S_758sI</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Sun, Zhaogui</creator><creator>Niu, Yanan</creator><creator>Yu, Lin</creator><creator>Shi, Yan</creator><creator>Cao, Yang</creator><creator>Zhuang, Meng-fei</creator><creator>Zhang, Ting-ting</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7531-9994</orcidid><orcidid>https://orcid.org/0000-0002-1919-1471</orcidid></search><sort><creationdate>2020</creationdate><title>Caulis Sargentodoxae Prescription Plays a Therapeutic Role with Decreased Inflammatory Cytokines in Peritoneal Fluid in the Rat Endometriosis Model</title><author>Sun, Zhaogui ; Niu, Yanan ; Yu, Lin ; Shi, Yan ; Cao, Yang ; Zhuang, Meng-fei ; Zhang, Ting-ting</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c499t-4dc2ee55315d980f4e8febd459b14632d5ce29498ed5d76a7e42de9fed1349bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Abdomen</topic><topic>Animal experimentation</topic><topic>Animal research</topic><topic>Anti-inflammatory drugs</topic><topic>Antibodies</topic><topic>Binding sites</topic><topic>Celecoxib</topic><topic>Chinese medicine</topic><topic>Cyclooxygenase-2</topic><topic>Cytokines</topic><topic>Drug dosages</topic><topic>Endometriosis</topic><topic>Endometrium</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Experiments</topic><topic>Health aspects</topic><topic>Immunohistochemistry</topic><topic>Infertility</topic><topic>Inflammation</topic><topic>Interleukin 1</topic><topic>Interleukin 2</topic><topic>Interleukin 6</topic><topic>Laboratory animals</topic><topic>Menstruation</topic><topic>mRNA</topic><topic>Oral administration</topic><topic>Ovariectomy</topic><topic>Ovaries</topic><topic>Peritoneal fluid</topic><topic>Peritoneum</topic><topic>Physiology</topic><topic>Polymerase chain reaction</topic><topic>Prostaglandin E2</topic><topic>Prostaglandin endoperoxide synthase</topic><topic>RNA</topic><topic>Transplantation</topic><topic>Tumor necrosis factor-α</topic><topic>Uterus</topic><topic>Western blotting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, Zhaogui</creatorcontrib><creatorcontrib>Niu, Yanan</creatorcontrib><creatorcontrib>Yu, Lin</creatorcontrib><creatorcontrib>Shi, Yan</creatorcontrib><creatorcontrib>Cao, Yang</creatorcontrib><creatorcontrib>Zhuang, Meng-fei</creatorcontrib><creatorcontrib>Zhang, Ting-ting</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Source</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Psychology Journals</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Evidence-based complementary and alternative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Zhaogui</au><au>Niu, Yanan</au><au>Yu, Lin</au><au>Shi, Yan</au><au>Cao, Yang</au><au>Zhuang, Meng-fei</au><au>Zhang, Ting-ting</au><au>Su, Shan-Yu</au><au>Shan-Yu Su</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Caulis Sargentodoxae Prescription Plays a Therapeutic Role with Decreased Inflammatory Cytokines in Peritoneal Fluid in the Rat Endometriosis Model</atitle><jtitle>Evidence-based complementary and alternative medicine</jtitle><addtitle>Evid Based Complement Alternat Med</addtitle><date>2020</date><risdate>2020</risdate><volume>2020</volume><issue>2020</issue><spage>1</spage><epage>9</epage><pages>1-9</pages><issn>1741-427X</issn><eissn>1741-4288</eissn><abstract>Caulis Sargentodoxae prescription has been confirmed by the gynecological clinical observation to be effective in the treatment of endometriosis (EMs), and inflammatory cytokines were involved in EMs. In this paper, animal experiments were designed to explain anti-inflammatory mechanisms of Caulis Sargentodoxae prescription on endometriosis. The EMs model was established by autoplastic transplantation, and rats were randomly divided into seven groups: normal control group, model group, ovariectomized group, gestrinone (Western medicine) group, Caulis Sargentodoxae prescription (Chinese medicine) group, celecoxib (inhibitor) group, and combination (Chinese medicine + inhibitor) group. After oral administration for 21 days, the growth inhibitory rates of the ectopic endometria in treatment groups were evaluated, and the levels of inflammatory cytokines in the serum and peritoneal fluid were determined by ELISA, as well as the expression of prostaglandin endoperoxide synthase 2 (PTGS2) in the ectopic endometrial tissues was detected by real-time polymerase chain reaction, immunohistochemistry, and western blotting. The growth inhibitory rates of the ectopic endometria were significantly higher in the Caulis Sargentodoxae prescription group and gestrinone group, in comparison with the model group p&lt;0.05. In the Caulis Sargentodoxae prescription group, the levels of inflammatory cytokines including IL-1, IL-2, IL-6, TNF-α, and PGE2 were all reduced in the serum and peritoneal fluid p&lt;0.05. In addition, the specific expression of PTGS2 in the ectopic endometrial tissues significantly decreased in the Caulis Sargentodoxae prescription group and PTGS2 inhibitor celecoxib group both at mRNA and protein levels, but in the steroid hormone drug gestrinone group not at the mRNA level. So, Caulis Sargentodoxae prescription has a reliable therapeutic effect on the EMs by its comprehensive anti-inflammatory roles, possibly in a way different from gestrinone.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>32595753</pmid><doi>10.1155/2020/9627907</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-7531-9994</orcidid><orcidid>https://orcid.org/0000-0002-1919-1471</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1741-427X
ispartof Evidence-based complementary and alternative medicine, 2020, Vol.2020 (2020), p.1-9
issn 1741-427X
1741-4288
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7275949
source Publicly Available Content Database; Wiley Open Access
subjects Abdomen
Animal experimentation
Animal research
Anti-inflammatory drugs
Antibodies
Binding sites
Celecoxib
Chinese medicine
Cyclooxygenase-2
Cytokines
Drug dosages
Endometriosis
Endometrium
Enzyme-linked immunosorbent assay
Experiments
Health aspects
Immunohistochemistry
Infertility
Inflammation
Interleukin 1
Interleukin 2
Interleukin 6
Laboratory animals
Menstruation
mRNA
Oral administration
Ovariectomy
Ovaries
Peritoneal fluid
Peritoneum
Physiology
Polymerase chain reaction
Prostaglandin E2
Prostaglandin endoperoxide synthase
RNA
Transplantation
Tumor necrosis factor-α
Uterus
Western blotting
title Caulis Sargentodoxae Prescription Plays a Therapeutic Role with Decreased Inflammatory Cytokines in Peritoneal Fluid in the Rat Endometriosis Model
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T09%3A59%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Caulis%20Sargentodoxae%20Prescription%20Plays%20a%20Therapeutic%20Role%20with%20Decreased%20Inflammatory%20Cytokines%20in%20Peritoneal%20Fluid%20in%20the%20Rat%20Endometriosis%20Model&rft.jtitle=Evidence-based%20complementary%20and%20alternative%20medicine&rft.au=Sun,%20Zhaogui&rft.date=2020&rft.volume=2020&rft.issue=2020&rft.spage=1&rft.epage=9&rft.pages=1-9&rft.issn=1741-427X&rft.eissn=1741-4288&rft_id=info:doi/10.1155/2020/9627907&rft_dat=%3Cgale_pubme%3EA635580280%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c499t-4dc2ee55315d980f4e8febd459b14632d5ce29498ed5d76a7e42de9fed1349bb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2410089670&rft_id=info:pmid/32595753&rft_galeid=A635580280&rfr_iscdi=true